DrugPatentWatch Database Preview
Queen Hamamatsu Pet Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for QUEEN HAMAMATSU PET, and what generic and branded alternatives to QUEEN HAMAMATSU PET drugs are available?
QUEEN HAMAMATSU PET has one approved drug.
Summary for Queen Hamamatsu Pet
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Queen Hamamatsu Pet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Queen Hamamatsu Pet | FLUDEOXYGLUCOSE F18 | fludeoxyglucose f-18 | INJECTABLE;INTRAVENOUS | 203771-001 | Aug 31, 2015 | AP | RX | No | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
